You are here: Profiles / Olaf Fjetland (List of Publications)
Tuesday, 23.05.2017

Olaf Fjetland - List of Publications

  1. W. Guy, G. Manov, W.H. Wilson, T.A. Ban, O.K. Fjetland, P.J. Manberg, A.T. Dren. Psychotropic Actions of BW 234U in the Treatment of Inpatient Schizophrenics: A Dose-Range Study.  Drug Development Research.  Vol. 3, 245-252, 1983.

  2. W. Guy, T.A. Ban, W.H. Wilson, O.K. Fjetland, K. Pate.  Depressive Subtypes and Treatment Outcome. In:Burrows G, ed. Biological Psychiatry. Recet Studies.London: John Libbey and company Ltd; 1983.

  3. W.  Guy, William H. Wilson, Thomas A. Ban, Douglas L. King, Gregory Manov, Olaf K. Fjetland.  A Double-Blind Clinical Trial of Fluvoxamine and Imipramine in Patients with Primary Depression.  Drug Development Research.  Vol. 4, 143-153, 1984.

  4. William Guy, William H. Wilson, Beth Brooking, Olaf K. Fjetland.  Intra-Interrater Reliability of SAFTEE Using Videotape Interviews and Clinical Trial Data.  Psychopharmacology Bulletin.  Vol. 23, No. 1, 1987.

  5. T.A. Ban, R.M. Panzarasa, S. Bora, D. Del Duchetto, O. Fjetland.  Choline Alphoscerate in Elderly Patients with Cognitive Decline Due to Dementing Illness.  New Trends in Clinical Neuropharmacology.  Vol. 5, 1991.

  6. Thomas A. Ban, Leslie C. Morey, Eugenio Aguglia, Rafael Batista, Giuseppe Campanella, Luciano Conti, Jean-Francois Dreyfus, Olaf K. Fjetland, Dario Grossi, Antionio Modaferri, Gustavo A. Marin-Perez, Alfredo Postiglione, Valerio Santini, Antiono Torres-Ruiz, Luis E. Vergara.  Glycosaminoglycan Polysulfate in the Treatment of Old Age Dementias.  Prog. Neuro-Psychopharmacol. & Biol. Psychiat.  Vol 15, 323-342, 1991.

  7. Thomas A. Ban, Leslie C. Morey, Olaf K. Fjetland, Franco Rengo, Niccola Ferrara, Virgilio Agnetti, Marina D'Onofrio, Giulio Facchini, Fernando Anzivino, Maria Alessandra Pergo, Chiara Danese, Antonio Capurso, Antonia Tommasi, Gualtiero Scardigli, Giovanni Jans, Lucilla Parnetti, Umberto Senin, Bruno Bergamasco.  Early Manifestations of Dementing Illness: Treatment with Glycosaminoglycan Polysulfate. Prog.Neuro-Psychopharmacol. & Biol. Psychiat, Vol. 16, pp. 662-676, 1992.

  8. Eugenio Aguglia, Thomas A. Ban, Rita M. Panzarasa, Simore Borra, Olaf K. Fjetland.  Choline alphoscerate in the Treatment of Mental Pathology Following Acute Cerebrovascular Accident.  Functional Neurology, Vol. VIII supplement, 1993.

  9. Thomas A. Ban, Olaf K. Fjetland, Mark Kutcher, Leslie C. Morey.  CODE-DD: Development of a Diagnostic Scale for Depressive Disorders.  Human Psychopharmacology. Vol. 4. Edited by I. Hindmarch and P. D. Stonier, 1993.

  10. L. Conti, G. Cassano, T.A. Ban, O.K. Fjetland, D. Grossi, F. Lazzerini, A. Modafferi, L.C. Morey, G.F. Placidi, A. Postiglione, F. Re, V. Santini.  Treatment of Primary Degenerative Dementia and Multi-Infarct Dementia with Glycosaminoglycan Polysulfate: A Comparison of Two Diagnoses and Two Doses.  Current Thereapeutic Research, Vol. 54, No. 1, July, 1993.

 

Olaf K.Fjetland

November 19, 2015